Lemon Bottle
Also known as: Lemon Bottle Fat Dissolver, Lemon Bottle lipolysis solution
Evidence Snapshot
Limited
None verified for complete formulation
Premixed liquid solution
10 mL vial
Key Takeaways
- No verified human clinical trials of the complete Lemon Bottle formulation have been identified.
- Riboflavin, bromelain, and lecithin have individual research, but that does not establish the blend's effectiveness or safety.
- Swissmedic (2024) found marketed samples inconsistent with advertised composition.
- The FDA (2025) issued warning letters identifying injectable LemonBottle marketing as unapproved new drugs.
- Advertised application volumes are commercial claims, not validated doses.
Table of Contents
1.Overview
Lemon Bottle is a cosmetic formulation marketed for localized fat reduction and body contouring. It is primarily associated with three advertised ingredients: riboflavin (vitamin B2), bromelain, and lecithin.
Commercial marketing describes the formulation as promoting fat metabolism, supporting the breakdown of localized fat deposits, and reducing inflammation or swelling.
Although some individual ingredients have been scientifically investigated, the complete Lemon Bottle formulation has not been demonstrated to produce effective or safe fat reduction in controlled human clinical trials.
2.Primary Ingredients and Proposed Mechanisms
Riboflavin (Vitamin B2)
Riboflavin is an essential water-soluble vitamin involved in cellular energy metabolism.
Established biological functions:
- Supports the formation of FMN and FAD coenzymes.
- Participates in mitochondrial energy production.
- Supports normal fatty-acid metabolism.
Research limitation: Its role in normal fat metabolism does not establish that administering additional riboflavin can selectively eliminate localized fat deposits.
Bromelain
Bromelain is a mixture of proteolytic enzymes derived from pineapple.
Investigated biological activities:
- Modulation of inflammatory pathways.
- Protein breakdown through enzymatic activity.
- Potential effects on swelling and tissue recovery.
Research limitation: Clinical studies primarily investigate oral or topical bromelain for other conditions. They do not establish that Lemon Bottle's bromelain content destroys human fat cells.
Lecithin
Lecithin is a mixture of phospholipids, including phosphatidylcholine, found in cell membranes.
Research interests:
- Membrane structure and lipid transport.
- Interactions between phospholipids and adipocytes.
- Experimental adipocyte viability and cell-membrane disruption.
Phosphatidylcholine has been investigated in experimental fat-reduction formulations, frequently combined with sodium deoxycholate.
The effects of these combinations cannot be attributed automatically to lecithin alone. Laboratory studies have produced differing findings concerning the individual contributions of phosphatidylcholine and deoxycholate.
Research limitation: These findings do not establish the fat-reduction effectiveness of Lemon Bottle.
3.Additional Advertised Ingredients
Published commercial ingredient information also identifies:
- Water
- Pineapple fruit extract
- Pentylene glycol
- Sodium chloride
- Centella asiatica extract
- Salvia miltiorrhiza root extract
- Chamomile extract
- Scutellaria baicalensis root extract
This is advertised composition information, not independent confirmation of the ingredients or their concentrations in every marketed vial.
4.Clinical Trials and Scientific Evidence
| Research category | Evidence status |
|---|---|
| Human fat-reduction trials | Not identified |
| Randomized placebo-controlled trials | Not identified |
| Demonstrated dose-response relationship | Not established |
| Long-term human safety | Not established |
| Individual ingredient research | Available |
| Validated treatment schedule | Not established |
Human clinical trials of the complete Lemon Bottle formulation: None identified in the reviewed published literature.
Research on riboflavin, bromelain, and phosphatidylcholine provides useful information about their biological properties. However, this research cannot establish the effectiveness, absorption, safety, or biological activity of the complete Lemon Bottle mixture.
5.Commercially Reported Application Volumes
| Anatomical area | Advertised volume |
|---|---|
| Double chin | 10β20 mL |
| Jawline / cheeks | 5β10 mL per zone |
| Upper arms | 10β15 mL per arm |
| Love handles | 15β25 mL per side |
| Abdomen | 30β40 mL |
| Inner thighs | 10β25 mL per side |
The following figures have appeared in manufacturer-associated and distributor marketing materials. These are historical commercial claims, not clinically validated doses or administration recommendations.
Figures for the jawline and cheeks come from distributor materials. Other ranges appear in manufacturer-associated listings. Published quantities vary across commercial sources. These values refer to liquid solution volume rather than measured milligram quantities of active ingredients.
Important limitations:
- No clinically established safe or effective dose exists for injectable Lemon Bottle.
- Commercially reported quantities have not been validated through controlled human studies.
- Neither a safe administration schedule nor a maximum safe exposure has been established.
- Published volume claims should not be interpreted as instructions for human administration.
6.Safety and Regulatory Research
Swissmedic Investigation β 2024
On March 26, 2024, the Swiss Agency for Therapeutic Products issued a warning concerning Lemon Bottle products marketed for injection.
Independent analysis of samples acquired from different sources identified inconsistencies between the advertised composition and laboratory findings. One analyzed sample contained caffeine as the only detected substance, while another lacked the advertised ingredients.
In a June 25, 2024 addendum, the Korean distributor, SID Medicos, disputed whether the samples were authentic and stated that its original Lemon Bottle Ampoule solution was intended exclusively for external cosmetic use, not injection.
These findings raise questions about product authenticity, formulation consistency, and unauthorized injectable use.
U.S. FDA Regulatory Findings β 2025
On March 3, 2025, the FDA issued warning letters to businesses marketing LemonBottle Ampoule Solution as an injectable fat-reduction treatment. The FDA identified the products as unapproved new drugs when marketed for those uses.
Lemon Bottle has no FDA-approved indication for injectable fat reduction.
Potential Safety Concerns
Regulatory authorities have identified serious complications involving unapproved fat-dissolving injections generally, including:
- Infection and inflammatory reactions
- Painful nodules and cysts
- Tissue damage
- Scarring and skin deformities
- Risks associated with inconsistent composition
These are category-level safety concerns and should not be mistaken for measured adverse-event rates specific to Lemon Bottle.
7.Comparison With Established Lipolysis Research
Deoxycholic acid has a substantially more developed clinical evidence base for reducing submental fat. FDA-approved deoxycholic acid products are indicated for improvement in the appearance of fat beneath the chin in adults.
Lemon Bottle is compositionally different and cannot inherit the clinical trial findings or regulatory approval of deoxycholic acid products.
8.Research Summary
Lemon Bottle is a commercially marketed formulation whose principal advertised ingredients have individually documented biochemical properties. However, the biological activity of individual ingredients is not sufficient evidence that the combined formulation safely or effectively reduces human body fat.
Current research gaps include:
- Independent confirmation of complete product composition
- Standardized concentrations and quality specifications
- Controlled human efficacy trials
- Human pharmacological and toxicological studies
- Validated dose-response findings
- Long-term safety data
9.Scientific and Regulatory References
- 1.NIH β Riboflavin: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Riboflavin-HealthProfessional/
- 2.Bromelain and Inflammatory Markers: Systematic Review.PMID: 37202035
- 3.Phosphatidylcholine and Sodium Deoxycholate in Human Adipose Tissue.PMID: 20646343
- 4.Swissmedic β Lemon Bottle Regulatory Investigation. https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/medicinal-products-from-the-internet/warnings-related-to-medicinal-products-from-the-internet/warnung-lemon-bottle.html
- 5.FDA β LemonBottle Warning Letter (Vivid Scientific LLC, 03/03/2025). https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vivid-scientific-llc-699226-03032025
- 6.FDA β Risks of Unapproved Fat-Dissolving Injections. https://www.fda.gov/drugs/buying-using-medicine-safely/using-fat-dissolving-injections-are-not-fda-approved-can-be-harmful
- 7.Commercial Product Information β SID Medicos Store. https://www.lemonbottle.net/products/lemon-bottle-fat-dissolver
- 8.Commercial Application Volume Reference β LemonBottle USA. https://www.lemonbottle.us/guide-on-how-to-use-it/
10.Axis Research Lab β Independent Scientific Education
This reference is provided for educational and scientific literature review. Commercial claims and historical quantities are presented for documentation, not as validated treatment instructions. Axis Research Lab is not affiliated with SID Medicos or the Lemon Bottle brand. This article does not recommend human administration or establish safety or effectiveness.
Research Goals
Linked Research Evidence (0)
Published studies and registry summaries. Trial registration alone is not evidence of efficacy.
No linked research articles yet.